Fudan-Zhangjiang places 100m yuan into China Merchants Bank structured deposits
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. and its wholly-owned subsidiary, Taizhou Fudan-Zhangjiang, have entered into two structured deposit product agreements with China Merchants Bank. The group subscribed for structured deposit products totaling 100m yuan, utilizing self-owned idle funds. Each agreement involves a principal amount of 50m yuan, with an expected annualized return rate ranging from 1.00% to 1.65% over a 76-day term, starting October 15, 2025.
These "Cautious Type" products offer principal-guaranteed floating returns linked to the gold price (XAU/USD). The return calculation involves the subscription amount multiplied by the actual annualized return rate and actual investment days, divided by 365. The actual annualized return rate varies based on the ending price relative to the starting price minus 352, with 1.00% if the ending price is less than this threshold and 1.65% if it is greater than or equal to it.
The transactions, aggregated under Listing Rule 14.22, constitute discloseable transactions as one or more applicable percentage ratios exceed 5% but are below 25%. The directors view these agreements as being on normal commercial terms, fair, reasonable, and in the best interest of the group and its shareholders.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Fudan-Zhangjiang Bio-PharmaLtd publishes news
Free account required • Unsubscribe anytime